CompletedEUCTR 2008-000766-23
Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study-
This historical record does not confirm current site availability.
Historical research recordGermanySchizophrenia
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Germany
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2008-000766-23
- Official title
Show the full official title
Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study-
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Germany
Registry details
Historical country statuses
- Germany — Completed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy.
